Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | HUMA | MOLN | ||
| Company | Sab Biotherapeutics Inc | Humacyte Inc | Molecular Partners Ag ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.78 | 0.9793 | 4.39 | ||
| High | 3.83 | 1.0400 | 4.39 | ||
| Low | 3.71 | 0.9500 | 4.21 | ||
| Latest | 3.77 | 0.9750 | 4.22 | ||
| Change | +0.03 | +0.0145 | -0.14 | ||
| % Change | +0.80% | +1.51% | -3.18% | ||
| Volume | 108,286 | 4,290,862 | 1,331 | ||
| 20-Day Average Volume | 295,114 | 4,932,443 | 3,867 | ||
| Previous Close | 3.74 | 0.9605 | 4.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.82 | 1.1443 | 4.33 | ||
| 20-Day Raw Stochastic | 60.26% | 15.12% | 44.12% | ||
| 20-Day Relative Strength | 53.82 | 35.66 | 49.99 | ||
| Weighted Alpha | +51.33 | -79.67 | -14.45 | ||
| Today's Opinion | 80% Buy | 100% Sell | 72% Buy | ||
| Previous Opinion | 80% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.82% since 12/24/25 | -9.72% since 12/24/25 | -2.76% since 12/24/25 | ||
| Low | 3.48 on 12/30/25 | 0.9100 on 12/31/25 | 4.16 on 12/26/25 | ||
| High | 3.87 on 12/26/25 | 1.1000 on 12/26/25 | 4.44 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | +3.57% since 12/02/25 | -22.62% since 12/02/25 | -2.31% since 12/02/25 | ||
| Low | 3.30 on 12/08/25 | 0.9100 on 12/31/25 | 3.92 on 12/15/25 | ||
| High | 4.08 on 12/05/25 | 1.3400 on 12/12/25 | 4.61 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +87.56% since 10/02/25 | -45.53% since 10/02/25 | +13.77% since 10/02/25 | ||
| Low | 1.97 on 10/03/25 | 0.9100 on 12/31/25 | 3.53 on 10/27/25 | ||
| High | 4.19 on 11/28/25 | 2.5500 on 10/06/25 | 4.75 on 11/07/25 | ||
| 6-Month | |||||
| %Chg | +115.43% since 07/02/25 | -57.79% since 07/02/25 | +12.23% since 07/02/25 | ||
| Low | 1.72 on 07/03/25 | 0.9100 on 12/31/25 | 3.41 on 08/01/25 | ||
| High | 6.60 on 07/21/25 | 2.8400 on 07/23/25 | 4.80 on 08/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 178,050 | 179,874 | 175,978 | ||
| Shares Outstanding, K | 47,607 | 187,271 | 40,375 | ||
| Annual Sales | 1,320,000 | 0 | 5,650,000 | ||
| Annual Net Income | -34,110,000 | -148,700,000 | -61,390,000 | ||
| Last Quarter Sales | 0 | 750,000 | 0 | ||
| Last Quarter Net Income | 45,450,000 | -17,510,000 | -14,790,000 | ||
| 60-Month Beta | 0.58 | 1.90 | 1.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/14/25 | -0.14 on 11/12/25 | -0.41 on 10/30/25 | ||
| Latest Earnings Date | 03/27/26 | 03/27/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||